Long-term HBsAg clearance, relapse, and safety following tenofovir or entecavir discontinuation in non-cirrhotic, HBeAg-negative chronic hepatitis

Abstract Stopping nucleos(t)ide analogues (NAs) can foster hepatitis B surface antigen (HBsAg) clearance, yet comparative data for tenofovir disoproxil fumarate (TDF) and entecavir (ETV) are scarce. We compared HBsAg loss, virological relapse (VR), clinical relapse (CR), and safety after stopping TD...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Onuma Sattayalertyanyong, Wimolrak Bandidniyamanon, Julajak Limsrivilai, Watcharasak Chotiyaputta, Supot Nimanong, Tawesak Tanwandee
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Nature Portfolio 2026-02-01
Reeks:	Scientific Reports
Onderwerpen:	Hepatitis B Chronic Hepatitis B surface antigens Entecavir Tenofovir Withholding treatment
Online toegang:	https://doi.org/10.1038/s41598-026-40972-y
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!